.jpeg)
What is the price of serpotinib/serpatinib after medical insurance?
Selpercatinib/Selpercatinibhas shown significant efficacy in treating cancers involving changes in the RET gene. These cancer types include RET fusion-positive non-small cell lung cancer, RET-altered medullary thyroid cancer, thyroid cancer, and other RET fusion-positive solid tumors. It was approved for marketing by the National Medical Products Administration in 2022, but it has not yet been included in the medical insurance list, which means that patients currently need to pay for the drug at their own expense. The original drug is sold in China under the name Seputinib , and the price per box of 80mg*56 capsules may be more than RMB 10,000.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
